Free Trial

Bard Associates Inc. Has $3.29 Million Holdings in Modular Medical, Inc. (NASDAQ:MODD)

Modular Medical logo with Medical background

Bard Associates Inc. raised its position in Modular Medical, Inc. (NASDAQ:MODD - Free Report) by 81.4% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,462,930 shares of the company's stock after acquiring an additional 656,330 shares during the period. Modular Medical comprises 1.1% of Bard Associates Inc.'s portfolio, making the stock its 25th biggest position. Bard Associates Inc. owned about 4.49% of Modular Medical worth $3,292,000 at the end of the most recent reporting period.

Separately, Renaissance Technologies LLC bought a new stake in shares of Modular Medical during the 2nd quarter worth approximately $40,000. Institutional investors own 27.47% of the company's stock.

Insider Buying and Selling at Modular Medical

In related news, Director Philip Brent Sheibley bought 15,000 shares of Modular Medical stock in a transaction dated Monday, August 19th. The shares were bought at an average cost of $1.69 per share, with a total value of $25,350.00. Following the acquisition, the director now owns 66,139 shares in the company, valued at $111,774.91. This trade represents a 29.33 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 32.34% of the company's stock.

Modular Medical Stock Performance

MODD traded down $0.07 during trading hours on Friday, reaching $2.07. The company's stock had a trading volume of 115,007 shares, compared to its average volume of 229,435. Modular Medical, Inc. has a 52 week low of $1.00 and a 52 week high of $2.65. The company's 50-day moving average is $2.23 and its 200-day moving average is $1.84. The firm has a market cap of $67.40 million, a PE ratio of -3.15 and a beta of 0.59.

Modular Medical (NASDAQ:MODD - Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.20) by $0.08.

Modular Medical Company Profile

(Free Report)

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Recommended Stories

Institutional Ownership by Quarter for Modular Medical (NASDAQ:MODD)

Should you invest $1,000 in Modular Medical right now?

Before you consider Modular Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Modular Medical wasn't on the list.

While Modular Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines